stockrowAmarin Corporation PLC (AMRN) vs Grifols, S.A. (GRFS)
- Amarin Corporation PLC AMRN 11.61 +0.26%
- Grifols, S.A. GRFS 8.43 −0.35%
Amarin Corporation PLC and Grifols, S.A. are both Drug Manufacturers General companies. Grifols, S.A. is the larger, with a market value of $2.2B against $244.0M — 8.9× the size. Amarin Corporation PLC has negative trailing earnings, so its P/E is not meaningful; Grifols, S.A. trades at 18.2×. Grifols, S.A. grew revenue faster over the last twelve months: 10.9% against −22.3%. Grifols, S.A. has the higher net margin (6.02% vs −10.9%) and the higher return on invested capital (4.76% vs −16.6%). Across the 21 metrics below, Grifols, S.A. leads on 11 and Amarin Corporation PLC on 10.
Valuation
Profitability
| Metric | AMRN | GRFS | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 40.94% | 37.55% | 73.01% |
| Operating margin | (18.19%) | 16.69% | 18.34% |
| Net margin | (10.87%) | 6.02% | 7.31% |
| Free cash flow margin | 21.29% | 8.51% | 18.56% |
| Return on equity | (4.24%) | 5.80% | 5.80% |
| Return on assets | (2.96%) | 2.28% | 2.28% |
| Return on invested capital | (16.57%) | 4.76% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack